These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31100351)

  • 1. Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?
    Kopecka J; Gazzano E; Castella B; Salaroglio IC; Mungo E; Massaia M; Riganti C
    Semin Cell Dev Biol; 2020 Feb; 98():80-89. PubMed ID: 31100351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer.
    Han Y; Cho U; Kim S; Park IS; Cho JH; Dhanasekaran DN; Song YS
    Free Radic Res; 2018 Dec; 52(11-12):1271-1287. PubMed ID: 29607684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolysis-induced drug resistance in tumors-A response to danger signals?
    Marcucci F; Rumio C
    Neoplasia; 2021 Feb; 23(2):234-245. PubMed ID: 33418276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment.
    Bosc C; Selak MA; Sarry JE
    Cell Metab; 2017 Nov; 26(5):705-707. PubMed ID: 29117545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Involvement in Cisplatin Resistance.
    Cocetta V; Ragazzi E; Montopoli M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer cell metabolism: Rewiring the mitochondrial hub.
    Oliveira GL; Coelho AR; Marques R; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.
    Zhang X; de Milito A; Olofsson MH; Gullbo J; D'Arcy P; Linder S
    Int J Mol Sci; 2015 Nov; 16(11):27313-26. PubMed ID: 26580606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance.
    Dorward A; Sweet S; Moorehead R; Singh G
    J Bioenerg Biomembr; 1997 Aug; 29(4):385-92. PubMed ID: 9387099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy.
    Dong L; Gopalan V; Holland O; Neuzil J
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative Stress and Reprogramming of Mitochondrial Function and Dynamics as Targets to Modulate Cancer Cell Behavior and Chemoresistance.
    Falone S; Lisanti MP; Domenicotti C
    Oxid Med Cell Longev; 2019; 2019():4647807. PubMed ID: 31915507
    [No Abstract]   [Full Text] [Related]  

  • 14. Links between cancer metabolism and cisplatin resistance.
    Cocetta V; Ragazzi E; Montopoli M
    Int Rev Cell Mol Biol; 2020; 354():107-164. PubMed ID: 32475471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells.
    Fonseca SB; Pereira MP; Mourtada R; Gronda M; Horton KL; Hurren R; Minden MD; Schimmer AD; Kelley SO
    Chem Biol; 2011 Apr; 18(4):445-53. PubMed ID: 21513881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and upcoming mitochondrial targets for cancer therapy.
    Kim HK; Noh YH; Nilius B; Ko KS; Rhee BD; Kim N; Han J
    Semin Cancer Biol; 2017 Dec; 47():154-167. PubMed ID: 28627410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2.
    Gallerne C; Prola A; Lemaire C
    Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Mitochondria-targeted Drugs for Cancer Therapy.
    Fialova JL; Raudenska M; Jakubek M; Kejik Z; Martasek P; Babula P; Matkowski A; Filipensky P; Masarik M
    Mini Rev Med Chem; 2021; 21(7):816-832. PubMed ID: 33213355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.